600 Ligases, Endless Possibilities

Maria Soloveychik says more than 600 E3 ligases offer a large opportunity for targeted protein degradation, with efforts underway to develop ligands against many of them. But while this could expand PROTAC design, bivalent molecules remain harder to develop than molecular glues because of their size, pharmacology, and dose-optimization challenges such as the hook effect.